UPDATE: Screening and Coverage for Diabetes and Prediabetes
Karin Gillespie, Changing Diabetes Policy, Novo Nordisk
UPDATE: Screening and Coverage for Diabetes and Prediabetes Karin - - PowerPoint PPT Presentation
UPDATE: Screening and Coverage for Diabetes and Prediabetes Karin Gillespie, Changing Diabetes Policy, Novo Nordisk 2 USPSTF Diabetes Screening Guideline 3 New USPSTF Abnormal Blood Glucose and Type 2 Diabetes Screening Guideline Experts
Karin Gillespie, Changing Diabetes Policy, Novo Nordisk
2
3
4
5
170 7.6 69.1 138.7 7.3 62.8 61.2 4.5 30.2 20 40 60 80 100 120 140 160 180 Number screened UDM detected UPDM detected 2015 USPSTF ADA 2008 USPSTF
Source: Analysis by Tim Dall for NNI, IHS Global insights, November 2014, Based on study published in American Journal of Preventive Medicine
6
Sources: Analysis of 2011 & 2013 Behavioral Risk Factor Surveillance System, 2013 American Community Survey, 2004 National Nursing Home Survey, and Census Bureau 2015 Population
Normoglycemia 1,604,000 49% Diagnosed diabetes 376,000 11% Undiagnosed diabetes 112,000 3% Diagnosed prediabetes 132,000 4% Undiagnosed prediabetes 1,081,000 33%
7
Adults without diagnosed diabetes 2,929,000 Meet USPSTF screening criteria 2,359,000 80.5% adults w/o DDM Normoglycemia 1,178,000 Diagnosed prediabetes 132,000 Undiagnosed diabetes 102,000 91.1% of UDM Undiagnosed prediabetes 947,000 87.6% of UPDM Do not meet USPSTF screening criteria Undiagnosed diabetes 10,000 8.9% of UDM Undiagnosed prediabetes 134,000 12.4% of UPDM Screened: Diabetes newly detected 23.1 Screened: Prediabetes newly detected 2.5
8
Notes: Numbers might not sum to totals because of rounding. * ‘Medicare’ category includes all adults age 65+ covered under a public insurance program; ‘Medicaid’ includes all adults under age 65 covered under a public insurance program (e.g., Medicare dual- eligible, Indian Health Services).
9
Commercial 398,000 49% Medicare (public assistance, age 65+) 166,000 21% Medicaid (public assistance, age <65) 100,000 12% Uninsured 141,000 18%
10
5 years 10 years 5 years 10 years New cases prevented Diabetes (141,000) (222,000)
Ischemic heart disease (10,000) (23,000)
Congestive heart failure (18,000) (6,000)
Stroke (12,400) (30,000)
Heart attack (7,000) (20,000)
Renal failure (4,900) (7,100)
Diabetic amputation (500) (2,000)
Diabetic retinopathy (2,700) (8,700)
Mortality (22,000) (66,000)
Additional years of life 52,000 292,000 0.1 0.4 Quality adjusted life years 105,700 370,500 0.1 0.5
11
5 years 10 years Reduced medical expenditures ($ millions) $3,419 $8,686 Non-medical economic benefits ($ millions) $4,368 $13,927 Higher household income ($ millions) $4,424 $13,854 Increased years of employment 46,700 167,200 Reduced missed work days 22,000 1,355,000 Absenteeism productivity gain ($ millions) $4 $209 Reduced long term disability ($ millions) $61 $136 Total economic benefits ($ millions) $7,786 $22,613
Note: Estimates take into account differences between state and national prices for medical care and wages
13
14
15
16
18
20
21